Skip to main content

Eton Pharmaceuticals, Inc 8-K, filed Nov 5, 2026

Eton Pharmaceuticals, Inc. (ETON)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

Eton Pharmaceuticals, Inc filed this 8-K on November 5, 2026.

Eton Pharmaceuticals said ET-700 produced fewer treatment-related adverse events than GALZIN in a pilot study, while hepatic copper uptake fell 12% with ET-700 versus 46% with GALZIN; it plans additional study arms in 2027 for faster-release formulations. AI summary

Items reported

  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits